WO2026042050 - NOVEL COMPOUNDS AND USES THEREOF
National phase entry is expected:
Publication Number
WO/2026/042050
Publication Date
26.02.2026
International Application No.
PCT/IB2025/058488
International Filing Date
22.08.2025
Title **
[English]
NOVEL COMPOUNDS AND USES THEREOF
[French]
NOUVEAUX COMPOSÉS ET LEURS UTILISATIONS
Applicants **
RECURSION PHARMACEUTICALS, INC.
Inventors
BOTTERILL, Simone Verene
COOKE, Andrew John
CASAUBON, Rebecca Lynn
RAY, Peter
KELLEY, Tanya
BARBEAU, Olivier Rémi
AHLSTEN, Nanna
MACIAS, Alba Teresa
Priority Data
2412464.6
23.08.2024
GB
2507532.6
15.05.2025
GB
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| Number of Office Actions | * |
| * | |
International Searching Authority |
EPO
* |
| Recordal of a Change of the Applicant's Name/Address |
Change of Applicant's Name and Address
* |
| Type of Assignment |
The Standard Agent's Assignment
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Patent Delivery |
Send the Letters Patent by Courier
* |
| Translation |
|
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing, Examination, Granting | 5738 | |
| EPO | Filing, Examination, Granting | 31118 | |
| Japan | Filing, Examination, Granting | 2958 | |
| South Korea | Filing, Examination, Granting | 3739 | |
| USA | Filing, Examination, Granting | 12240 |
Total:
55,793
Contact Us
Abstract[English]
Disclosed are novel compounds according to formula (1), their pharmaceutically acceptable salts, and pharmaceutical compositions thereof. Also disclosed are methods of using such compounds and compositions to treat various diseases including cancer and proliferative diseases and disorders.[French]
L'invention concerne de nouveaux composés selon la formule (1), leurs sels pharmaceutiquement acceptables, et des compositions pharmaceutiques de ceux-ci. L'invention concerne également des procédés d'utilisation de tels composés et compositions pour traiter diverses maladies tels que le cancer et des maladies et des troubles prolifératifs.